Literature DB >> 22515342

Determining a minimal safe distance to prevent thermal injury to intrahepatic bile ducts in radiofrequency ablation of the liver: a study in dogs.

Nianzhou Liu1, Jun Gao, Yongkang Liu, Tingjun Li, Kai Feng, Kuansheng Ma, Jiahong Dong, Xiaowu Li, Shuguang Wang, Ping Bie.   

Abstract

PURPOSE: To determine a minimal safe distance between the radiofrequency ablation (RFA) electrode tip and major intrahepatic bile ducts to prevent thermal injury during hepatic RFA in a canine model.
MATERIALS AND METHODS: Forty healthy mongrel dogs were randomised equally into four groups based on the distance between the electrode and large intrahepatic bile ducts during RFA of the liver, as follows: 1.0-2.9 mm, 3.0-4.9 mm, 5.0-7.9 mm, or 8.0-10.0 mm. The RFA electrodes were opened uniformly at 2 cm. During RFA, energy was sequentially raised, starting at 5 W and increasing by 5 W increments every minute to a maximum of 95 W. Animals were monitored for a maximum of 14 days post-RFA for complications and by bilirubin testing, after which they were euthanised and their livers were surgically removed for cholangiographic and pathological examination.
RESULTS: When the electrodes were less than 5.0 mm from the bile ducts during RFA, either full or partial-thickness bile duct necrosis occurred, leading to a variety of serious complications. In contrast, when the distance was more than 5.0 mm between the RFA electrode and bile ducts, serious complications occurred rarely, with pathological examinations showing either normal bile ducts or vacuolar changes of the biliary ductal epithelium.
CONCLUSION: A minimum safe distance of 5.0 mm between the RFA electrode and intrahepatic bile ducts was effective in preventing serious complications secondary to bile duct injury in a canine model.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22515342     DOI: 10.3109/02656736.2012.661915

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  4 in total

1.  Percutaneous electrochemotherapy in the treatment of portal vein tumor thrombosis at hepatic hilum in patients with hepatocellular carcinoma in cirrhosis: A feasibility study.

Authors:  Luciano Tarantino; Giuseppina Busto; Aurelio Nasto; Raffaele Fristachi; Luigi Cacace; Maria Talamo; Catello Accardo; Sara Bortone; Paolo Gallo; Paolo Tarantino; Riccardo Aurelio Nasto; Matteo Nicola Dario Di Minno; Pasquale Ambrosino
Journal:  World J Gastroenterol       Date:  2017-02-07       Impact factor: 5.742

2.  No-touch radiofrequency ablation using multiple electrodes: An in vivo comparison study of switching monopolar versus switching bipolar modes in porcine livers.

Authors:  Won Chang; Jeong Min Lee; Jeong Hee Yoon; Dong Ho Lee; Sang Min Lee; Kyoung Bun Lee; Bo Ram Kim; Tae-Hyung Kim; Seunghyun Lee; Joon Koo Han
Journal:  PLoS One       Date:  2017-04-26       Impact factor: 3.240

3.  Advances in the interventional therapy of hepatocellular carcinoma originating from the caudate lobe.

Authors:  Shanmiao Ke
Journal:  J Interv Med       Date:  2022-05-21

Review 4.  Ultrasound-Guided Percutaneous Radiofrequency Ablation of Liver Tumors: How We Do It Safely and Completely.

Authors:  Jin Woong Kim; Sang Soo Shin; Suk Hee Heo; Jun Hyung Hong; Hyo Soon Lim; Hyun Ju Seon; Young Hoe Hur; Chang Hwan Park; Yong Yeon Jeong; Heoung Keun Kang
Journal:  Korean J Radiol       Date:  2015-10-26       Impact factor: 3.500

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.